20:24 IST
NSE
Other Announcement
Gland Pharma Other Announcement
Gland Pharma Limited submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, as per SEBI regulations.
Gland Pharma Ltd
Gland Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,115.60
- Market cap
- ₹51,411 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 45.5×Sector 47.4×
- Promoter holding
- 51.77%-0.06% QoQ
- FII holding
- 8.74%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 3Earnings Call 3Business Update 3Annual General Meeting 3Other Announcement 2Management Change 2Employee Stock Options 2Results Update 1Promoter Selling 1Product Launch 1New Order Win 1Merger & Restructuring 1Financial Results 1Capital Structure Change 1Capacity Expansion 1Board Meeting Date 1Acquisition 1
Time
2 announcements with these filters
17:40 IST
BSE
Other Announcement
Gland Pharma Other Announcement
Gland Pharma submitted its quarterly shareholding pattern for the period ending June 30, 2026. This is a routine regulatory disclosure.